Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 222

1.

Tumour Growth Rate as a validated early radiological biomarker able to reflect treatment-induced changes in Neuroendocrine Tumours; the GREPONET-2 study.

Lamarca A, Ronot M, Moalla S, Crona J, Opalinska M, Lopez Lopez C, Pezzutti D, Najran P, Carvalho LFDP, Bezerra ROF, Borg P, Vietti Violi N, Vidal Trueba H, de Mestier L, Schaefer N, Baudin E, Sundin A, Costa FP, Pavel M, Dromain C.

Clin Cancer Res. 2019 Aug 2. pii: clincanres.0963.2019. doi: 10.1158/1078-0432.CCR-19-0963. [Epub ahead of print]

PMID:
31375514
2.

Tumor-to-blood ratio for assessment of somatostatin receptor density in neuroendocrine tumors using 68Ga-DOTATOC and 68Ga-DOTATATE.

Ilan E, Velikyan I, Sandström M, Sundin A, Lubberink M.

J Nucl Med. 2019 Jul 13. pii: jnumed.119.228072. doi: 10.2967/jnumed.119.228072. [Epub ahead of print]

PMID:
31302632
3.

Regularized reconstruction of digital time-of-flight 68Ga-PSMA-11 PET/CT for the detection of recurrent disease in prostate cancer patients.

Lindström E, Velikyan I, Regula N, Alhuseinalkhudhur A, Sundin A, Sörensen J, Lubberink M.

Theranostics. 2019 May 25;9(12):3476-3484. doi: 10.7150/thno.31970. eCollection 2019.

4.

Favorable Outcome in Patients with Pheochromocytoma and Paraganglioma Treated with 177Lu-DOTATATE.

Vyakaranam AR, Crona J, Norlén O, Granberg D, Garske-Román U, Sandström M, Fröss-Baron K, Thiis-Evensen E, Hellman P, Sundin A.

Cancers (Basel). 2019 Jun 28;11(7). pii: E909. doi: 10.3390/cancers11070909.

5.

11C-hydroxy-ephedrine-PET/CT in the Diagnosis of Pheochromocytoma and Paraganglioma.

Vyakaranam AR, Crona J, Norlén O, Hellman P, Sundin A.

Cancers (Basel). 2019 Jun 19;11(6). pii: E847. doi: 10.3390/cancers11060847.

6.

Response to Prof. Ingo Brink and Prof. Aubalewska-Dydejczyk regarding Their "Letter to the Editor".

Sundin A, Fanti S, Giammarile F, de Herder WW.

Neuroendocrinology. 2019;108(4):366. doi: 10.1159/000497419. Epub 2019 Mar 27. No abstract available.

PMID:
30917382
7.

Value of Tumor Growth Rate (TGR) as an Early Biomarker Predictor of Patients' Outcome in Neuroendocrine Tumors (NET)-The GREPONET Study.

Lamarca A, Crona J, Ronot M, Opalinska M, Lopez Lopez C, Pezzutti D, Najran P, Carvhalo L, Franca Bezerra RO, Borg P, Vietti Violi N, Vidal Trueba H, de Mestier L, Schaefer N, Sundin A, Costa F, Pavel M, Dromain C; Knowledge Network.

Oncologist. 2019 Mar 25. pii: theoncologist.2018-0672. doi: 10.1634/theoncologist.2018-0672. [Epub ahead of print]

PMID:
30910869
8.

Unmet Needs in Functional and Nonfunctional Pancreatic Neuroendocrine Neoplasms.

Jensen RT, Bodei L, Capdevila J, Couvelard A, Falconi M, Glasberg S, Kloppel G, Lamberts S, Peeters M, Rindi G, Rinke A, Rothmund M, Sundin A, Welin S, Fazio N; The ENETS 2016 Munich Advisory Board Participants; ENETS 2016 Munich Advisory Board Participants.

Neuroendocrinology. 2019;108(1):26-36. doi: 10.1159/000494258. Epub 2018 Oct 3.

PMID:
30282083
9.

Colorectal Neuroendocrine Neoplasms: Areas of Unmet Need.

Ramage JK, Valle JW, Nieveen van Dijkum EJM, Sundin A, Pascher A, Couvelard A, Kloeppel G; the ENETS 2016 Munich Advisory Board Participants; ENETS 2016 Munich Advisory Board Participants.

Neuroendocrinology. 2019;108(1):45-53. doi: 10.1159/000493767. Epub 2018 Sep 16.

PMID:
30219817
10.

Quinoline-galactose hybrids bind selectively with high affinity to a galectin-8 N-terminal domain.

Pal KB, Mahanti M, Huang X, Persson S, Sundin AP, Zetterberg FR, Oredsson S, Leffler H, Nilsson UJ.

Org Biomol Chem. 2018 Aug 29;16(34):6295-6305. doi: 10.1039/c8ob01354c.

PMID:
30117507
11.

Novel Functional Imaging of Neuroendocrine Tumors.

Sundin A.

Endocrinol Metab Clin North Am. 2018 Sep;47(3):505-523. doi: 10.1016/j.ecl.2018.04.003. Epub 2018 Jul 11. Review.

PMID:
30098713
12.

Designing interactions by control of protein-ligand complex conformation: tuning arginine-arene interaction geometry for enhanced electrostatic protein-ligand interactions.

Noresson AL, Aurelius O, Öberg CT, Engström O, Sundin AP, Håkansson M, Stenström O, Akke M, Logan DT, Leffler H, Nilsson UJ.

Chem Sci. 2017 Dec 4;9(4):1014-1021. doi: 10.1039/c7sc04749e. eCollection 2018 Jan 28.

13.

Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity.

Garske-Román U, Sandström M, Fröss Baron K, Lundin L, Hellman P, Welin S, Johansson S, Khan T, Lundqvist H, Eriksson B, Sundin A, Granberg D.

Eur J Nucl Med Mol Imaging. 2018 Jun;45(6):970-988. doi: 10.1007/s00259-018-3945-z. Epub 2018 Mar 1.

14.

Evaluation of Penalized-Likelihood Estimation Reconstruction on a Digital Time-of-Flight PET/CT Scanner for 18F-FDG Whole-Body Examinations.

Lindström E, Sundin A, Trampal C, Lindsjö L, Ilan E, Danfors T, Antoni G, Sörensen J, Lubberink M.

J Nucl Med. 2018 Jul;59(7):1152-1158. doi: 10.2967/jnumed.117.200790. Epub 2018 Feb 15.

15.

Anatomic distribution of hematoma following pelvic fracture.

Uludag N, Tötterman A, Beckman MO, Sundin A.

Br J Radiol. 2018 May;91(1085):20170840. doi: 10.1259/bjr.20170840. Epub 2018 Feb 22.

16.

Preoperative 68Ga-DOTA-Somatostatin Analog-PET/CT Hybrid Imaging Increases Detection Rate of Intra-abdominal Small Intestinal Neuroendocrine Tumor Lesions.

Norlén O, Montan H, Hellman P, Stålberg P, Sundin A.

World J Surg. 2018 Feb;42(2):498-505. doi: 10.1007/s00268-017-4364-1.

17.

Local irradiation does not enhance the effect of immunostimulatory AdCD40L gene therapy combined with low dose cyclophosphamide in melanoma patients.

Irenaeus S, Schiza A, Mangsbo SM, Wenthe J, Eriksson E, Krause J, Sundin A, Ahlström H, Tötterman TH, Loskog A, Ullenhag GJ.

Oncotarget. 2017 Jul 31;8(45):78573-78587. doi: 10.18632/oncotarget.19750. eCollection 2017 Oct 3.

18.

[Swedish guidelines for the management of adrenal incidentalomas].

Muth A, Hammarstedt L, Hellström M, Nyman U, Sundin A, Wahrenberg H, Wängberg B.

Lakartidningen. 2017 Sep 29;114. pii: ETD6. Review. Swedish.

19.

Kidney dosimetry during 177Lu-DOTATATE therapy in patients with neuroendocrine tumors: aspects on calculation and tolerance.

Sandström M, Garske-Román U, Johansson S, Granberg D, Sundin A, Freedman N.

Acta Oncol. 2018 Apr;57(4):516-521. doi: 10.1080/0284186X.2017.1378431. Epub 2017 Sep 18.

PMID:
28920501
20.

Erratum to: Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F-DOPA.

Bozkurt MF, Virgolini I, Balogova S, Beheshti M, Rubello D, Decristoforo C, Ambrosini V, Kjaer A, Delgado-Bolton R, Kunikowska J, Oyen WJG, Chiti A, Giammarile F, Sundin A, Fanti S.

Eur J Nucl Med Mol Imaging. 2017 Nov;44(12):2150-2151. doi: 10.1007/s00259-017-3807-0. No abstract available.

PMID:
28856372
21.

Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F-DOPA.

Bozkurt MF, Virgolini I, Balogova S, Beheshti M, Rubello D, Decristoforo C, Ambrosini V, Kjaer A, Delgado-Bolton R, Kunikowska J, Oyen WJG, Chiti A, Giammarile F, Sundin A, Fanti S.

Eur J Nucl Med Mol Imaging. 2017 Aug;44(9):1588-1601. doi: 10.1007/s00259-017-3728-y. Epub 2017 May 25. Erratum in: Eur J Nucl Med Mol Imaging. 2017 Aug 30;:.

PMID:
28547177
22.

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine & Hybrid Imaging.

Sundin A, Arnold R, Baudin E, Cwikla JB, Eriksson B, Fanti S, Fazio N, Giammarile F, Hicks RJ, Kjaer A, Krenning E, Kwekkeboom D, Lombard-Bohas C, O'Connor JM, O'Toole D, Rockall A, Wiedenmann B, Valle JW, Vullierme MP; Antibes Consensus Conference participants.

Neuroendocrinology. 2017;105(3):212-244. doi: 10.1159/000471879. Epub 2017 Mar 30. No abstract available.

PMID:
28355596
23.

ENETS Consensus Recommendations for the Standards of Care in Neuroendocrine Neoplasms: Follow-Up and Documentation.

Knigge U, Capdevila J, Bartsch DK, Baudin E, Falkerby J, Kianmanesh R, Kos-Kudla B, Niederle B, Nieveen van Dijkum E, O'Toole D, Pascher A, Reed N, Sundin A, Vullierme MP; Antibes Consensus Conference Participants; Antibes Consensus Conference participants.

Neuroendocrinology. 2017;105(3):310-319. doi: 10.1159/000458155. Epub 2017 Feb 17. No abstract available.

24.

B-cell posttransplant lymphoproliferative disorder isolated to the central nervous system is Epstein-Barr virus positive and lacks p53 and Myc expression by immunohistochemistry.

Sundin A, Grzywacz BJ, Yohe S, Linden MA, Courville EL.

Hum Pathol. 2017 Mar;61:140-147. doi: 10.1016/j.humpath.2016.12.007. Epub 2016 Dec 16.

PMID:
27993575
25.

Preoperative MR staging of cervical carcinoma: are oblique and contrast-enhanced sequences necessary?

Fridsten S, Hellström AC, Hellman K, Sundin A, Söderén B, Blomqvist L.

Acta Radiol Open. 2016 Nov 22;5(11):2058460116679460. eCollection 2016 Nov.

26.

SPECT/CT's Advantage for Preoperative Localization of Small Parathyroid Adenomas in Primary Hyperparathyroidism.

Sandqvist P, Nilsson IL, Grybäck P, Sanchez-Crespo A, Sundin A.

Clin Nucl Med. 2017 Feb;42(2):e109-e114. doi: 10.1097/RLU.0000000000001447.

PMID:
27819859
27.

Parametric Net Influx Rate Images of 68Ga-DOTATOC and 68Ga-DOTATATE: Quantitative Accuracy and Improved Image Contrast.

Ilan E, Sandström M, Velikyan I, Sundin A, Eriksson B, Lubberink M.

J Nucl Med. 2017 May;58(5):744-749. doi: 10.2967/jnumed.116.180380. Epub 2016 Oct 27.

28.

18F-FDG PET/CT Diagnosis of Bronchopulmonary Carcinoids Versus Pulmonary Hamartomas: Reply.

Sundin A, Uhlén N, Axelsson R.

Clin Nucl Med. 2017 Jan;42(1):81-82. No abstract available.

PMID:
27607160
29.

A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management.

Oberg K, Krenning E, Sundin A, Bodei L, Kidd M, Tesselaar M, Ambrosini V, Baum RP, Kulke M, Pavel M, Cwikla J, Drozdov I, Falconi M, Fazio N, Frilling A, Jensen R, Koopmans K, Korse T, Kwekkeboom D, Maecke H, Paganelli G, Salazar R, Severi S, Strosberg J, Prasad V, Scarpa A, Grossman A, Walenkamp A, Cives M, Virgolini I, Kjaer A, Modlin IM.

Endocr Connect. 2016 Sep;5(5):174-87. doi: 10.1530/EC-16-0043. Epub 2016 Aug 31.

30.

Predictive value of [18F]-fluoride PET for monitoring bone remodeling in patients with orthopedic conditions treated with a Taylor spatial frame.

Sanchez-Crespo A, Christiansson F, Thur CK, Lundblad H, Sundin A.

Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):441-448. doi: 10.1007/s00259-016-3459-5. Epub 2016 Jul 23.

PMID:
27448575
31.

Immunostimulatory AdCD40L gene therapy combined with low-dose cyclophosphamide in metastatic melanoma patients.

Loskog A, Maleka A, Mangsbo S, Svensson E, Lundberg C, Nilsson A, Krause J, Agnarsdóttir M, Sundin A, Ahlström H, Tötterman TH, Ullenhag G.

Br J Cancer. 2016 Apr 12;114(8):872-80. doi: 10.1038/bjc.2016.42. Epub 2016 Mar 31.

32.

Adrenal Molecular Imaging.

Sundin A.

Front Horm Res. 2016;45:70-9. doi: 10.1159/000442317. Epub 2016 Mar 15. Review.

PMID:
27003680
33.

Imaging of Neuroendocrine Tumors.

Öberg K, Sundin A.

Front Horm Res. 2016;45:142-51. doi: 10.1159/000442331. Epub 2016 Mar 15. Review.

PMID:
27002535
34.

Multidetector CT of pancreatic ductal adenocarcinoma: Effect of tube voltage and iodine load on tumour conspicuity and image quality.

Loizou L, Albiin N, Leidner B, Axelsson E, Fischer MA, Grigoriadis A, Del Chiaro M, Segersvärd R, Verbeke C, Sundin A, Kartalis N.

Eur Radiol. 2016 Nov;26(11):4021-4029. Epub 2016 Mar 10.

PMID:
26965503
35.

18F-FDG PET/CT Diagnosis of Bronchopulmonary Carcinoids Versus Pulmonary Hamartomas.

Uhlén N, Grundberg O, Jacobsson H, Sundin A, Dobra K, Sánchez-Crespo A, Axelsson R, Kölbeck KG.

Clin Nucl Med. 2016 Apr;41(4):263-7. doi: 10.1097/RLU.0000000000001114.

PMID:
26828139
36.

ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms.

Delle Fave G, O'Toole D, Sundin A, Taal B, Ferolla P, Ramage JK, Ferone D, Ito T, Weber W, Zheng-Pei Z, De Herder WW, Pascher A, Ruszniewski P; Vienna Consensus Conference participants.

Neuroendocrinology. 2016;103(2):119-24. doi: 10.1159/000443168. Epub 2016 Jan 19. No abstract available.

PMID:
26784901
37.

Assessment of Whether Patients' Knowledge, Satisfaction, and Experience Regarding Their 18F-Fluoride PET/CT Examination Affects Image Quality.

Andersson C, Johansson B, Wassberg C, Johansson S, Sundin A, Ahlström H.

J Nucl Med Technol. 2016 Mar;44(1):21-5. doi: 10.2967/jnmt.115.167536. Epub 2016 Jan 14.

38.

ENETS Consensus Guidelines Update for Colorectal Neuroendocrine Neoplasms.

Ramage JK, De Herder WW, Delle Fave G, Ferolla P, Ferone D, Ito T, Ruszniewski P, Sundin A, Weber W, Zheng-Pei Z, Taal B, Pascher A; Vienna Consensus Conference participants.

Neuroendocrinology. 2016;103(2):139-43. doi: 10.1159/000443166. Epub 2016 Jan 5. No abstract available.

PMID:
26730835
39.

Radiological Imaging: Computed Tomography, Magnetic Resonance Imaging and Ultrasonography.

Sundin A, Wills M, Rockall A.

Front Horm Res. 2015;44:58-72. doi: 10.1159/000382056. Epub 2015 Aug 14. Review.

PMID:
26303704
40.

Streptozocin and 5-Fluorouracil for the Treatment of Pancreatic Neuroendocrine Tumors: Efficacy, Prognostic Factors and Toxicity.

Clewemar Antonodimitrakis P, Sundin A, Wassberg C, Granberg D, Skogseid B, Eriksson B.

Neuroendocrinology. 2016;103(3-4):345-53. doi: 10.1159/000439086. Epub 2015 Aug 7.

PMID:
26279284
41.

Evaluation of a new system for chest tomosynthesis: aspects of image quality of different protocols determined using an anthropomorphic phantom.

Jadidi M, Sundin A, Aspelin P, Båth M, Nyrén S.

Br J Radiol. 2015 Sep;88(1053):20150057. doi: 10.1259/bjr.20150057. Epub 2015 Jun 29.

42.

A Remarkably Complex Supramolecular Hydrogen-Bonded Decameric Capsule Formed from an Enantiopure C₂-Symmetric Monomer by Solvent-Responsive Aggregation.

Račkauskaitė D, Bergquist KE, Shi Q, Sundin A, Butkus E, Wärnmark K, Orentas E.

J Am Chem Soc. 2015 Aug 26;137(33):10536-46. doi: 10.1021/jacs.5b03160. Epub 2015 May 21.

PMID:
25950402
43.

Recent developments in imaging of pancreatic neuroendocrine tumors.

Kartalis N, Mucelli RM, Sundin A.

Ann Gastroenterol. 2015 Apr-Jun;28(2):193-202. Review.

44.

Dose response of pancreatic neuroendocrine tumors treated with peptide receptor radionuclide therapy using 177Lu-DOTATATE.

Ilan E, Sandström M, Wassberg C, Sundin A, Garske-Román U, Eriksson B, Granberg D, Lubberink M.

J Nucl Med. 2015 Feb;56(2):177-82. doi: 10.2967/jnumed.114.148437. Epub 2015 Jan 15.

45.

Haemophilus influenzae surface fibril (Hsf) is a unique twisted hairpin-like trimeric autotransporter.

Singh B, Jubair TA, Mörgelin M, Sundin A, Linse S, Nilsson UJ, Riesbeck K.

Int J Med Microbiol. 2015 Jan;305(1):27-37. doi: 10.1016/j.ijmm.2014.10.004. Epub 2014 Oct 27.

PMID:
25465160
46.

Iridium catalyzed carbocyclizations: efficient (5+2) cycloadditions of vinylcyclopropanes and alkynes.

Melcher MC, von Wachenfeldt H, Sundin A, Strand D.

Chemistry. 2015 Jan 7;21(2):531-5. doi: 10.1002/chem.201405729. Epub 2014 Nov 20.

PMID:
25413863
47.

Ileal neuroendocrine tumors and heart: not only valvular consequences.

Calissendorff J, Maret E, Sundin A, Falhammar H.

Endocrine. 2015 Apr;48(3):743-55. doi: 10.1007/s12020-014-0446-0. Epub 2014 Oct 16. Review.

PMID:
25319177
48.

The status of neuroendocrine tumor imaging: from darkness to light?

Bodei L, Sundin A, Kidd M, Prasad V, Modlin IM.

Neuroendocrinology. 2015;101(1):1-17. doi: 10.1159/000367850. Epub 2014 Sep 10.

49.

Static and dynamic CT imaging of the cervical spine in patients with rheumatoid arthritis.

Söderman T, Olerud C, Shalabi A, Alavi K, Sundin A.

Skeletal Radiol. 2015 Feb;44(2):241-8. doi: 10.1007/s00256-014-2000-9. Epub 2014 Sep 18.

PMID:
25227660
50.

Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms.

Janson ET, Sorbye H, Welin S, Federspiel B, Grønbæk H, Hellman P, Ladekarl M, Langer SW, Mortensen J, Schalin-Jäntti C, Sundin A, Sundlöv A, Thiis-Evensen E, Knigge U.

Acta Oncol. 2014 Oct;53(10):1284-97. doi: 10.3109/0284186X.2014.941999. Epub 2014 Aug 20. Review.

PMID:
25140861

Supplemental Content

Loading ...
Support Center